ESR1 and breast cancer: Furthermore, genetic silencing or chemical inhibition of menin has been shown to reduce proliferation of ER+ breast cancer cell lines via down-regulation of a cancer-specific gene expression program including the estrogen receptor gene (ESR1) itself [8].